"The risk of approving a vaccine prematurely, for us, is that first of all, it will make it very difficult to continue with randomized clinical trials," Dr. Soumya Swaminathan, the World Health Organization's chief scientist, warned.
from Health and Science https://ift.tt/2DdfcaC
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH
No comments:
Post a Comment